OTC Markets Unveils ‘Blue Sky’ Compliance Dataset for OTC Securities
The dataset is part of an ongoing initiative by the OTC marketplace to gain state-by-state exemptions to allow brokers and issuers to conduct business in OTC securities.
New York-based over-the-counter equities market operator OTC Markets has released the Blue Sky Data Product to help broker-dealers and investment advisors ensure their research and recommendations are compliant with regulatory requirements around unlisted securities in each US state, jurisdiction, and territory.
“Blue Sky” laws govern what activities brokers can perform in certain OTC securities, and are set on a state-by-state level. Brokers require exemptions from each state to solicit or provide services like research in OTC securities. And while OTC Markets is working with states to obtain exemptions for the OTC securities traded on its platforms—and has obtained exemptions from 37 states for its OTCQX market and 33 states for its OTCQB market so far—brokers have generally needed to obtain individual exemptions, or to simply not provide research on OTC securities, which inhibits liquidity in these stocks, says Matthew Fuchs, EVP of market data and strategy at OTC Markets Group.
The Blue Sky Data Product evaluates state rules for each security—covering 16,000 equities and 80,000 OTC fixed income securities—and identifies whether an exemption exits for OTC securities in each state, using a rules engine built by OTC Markets to catalog the inconsistencies between each state. OTC Markets then makes the data available via its Canari front end, and in a flat text file that firms can capture into their databases to identify which securities they can solicit business for or discuss with clients, and use in their order management systems to block solicitation in any non-exempt securities.
“This is a way to simplify and automate a complex, manual, and costly regulatory regime, reduce costs, and help issuers leverage broker and wealth management platforms to help tell their story,” Fuchs says.
Many of the exceptions depend on disclosure, and on demonstrating that disclosures are available and current, Fuchs says. “So we show how, to be part of our markets, companies must make disclosures available via our website… and we ask states to create an exception,” he says.
Users of the product are expected to be compliance analysts, or legal or risk professionals, rather than trading desks deciding who they can approach to trade certain securities. OTC Markets will also make the data available to issuers of OTC securities so they can see where exemptions exist and target investor relations activities accordingly.
“The benefits for issuers are that they can use broker-dealers to provide research … to attract a more diverse investor base, and also attract more liquidity,” Fuchs says. “In the short term, we are trying to solve a tangible problem. The long-term goal is to make working with OTC securities from a compliance and risk perspective on-par with the listed world. We want to provide compliance analysts with the data to evaluate risk and reduce friction in the OTC space. This will help issuers, participants, and will make the market more liquid overall.”
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Data Management
New working group to create open framework for managing rising market data costs
Substantive Research is putting together a working group of market data-consuming firms with the aim of crafting quantitative metrics for market data cost avoidance.
Off-channel messaging (and regulators) still a massive headache for banks
Waters Wrap: Anthony wonders why US regulators are waging a war using fines, while European regulators have chosen a less draconian path.
Back to basics: Data management woes continue for the buy side
Data management platform Fencore helps investment managers resolve symptoms of not having a central data layer.
‘Feature, not a bug’: Bloomberg makes the case for Figi
Bloomberg created the Figi identifier, but ceded all its rights to the Object Management Group 10 years ago. Here, Bloomberg’s Richard Robinson and Steve Meizanis write to dispel what they believe to be misconceptions about Figi and the FDTA.
SS&C builds data mesh to unite acquired platforms
The vendor is using GenAI and APIs as part of the ongoing project.
Aussie asset managers struggle to meet ‘bank-like’ collateral, margin obligations
New margin and collateral requirements imposed by UMR and its regulator, Apra, are forcing buy-side firms to find tools to help.
Where have all the exchange platform providers gone?
The IMD Wrap: Running an exchange is a profitable business. The margins on market data sales alone can be staggering. And since every exchange needs a reliable and efficient exchange technology stack, Max asks why more vendors aren’t diving into this space.
Reading the bones: Citi, BNY, Morgan Stanley invest in AI, alt data, & private markets
Investment arms at large US banks are taken with emerging technologies such as generative AI, alternative and unstructured data, and private markets as they look to partner with, acquire, and invest in leading startups.